- Home
- CXAI vs OVID Comparison
CXAI vs OVID Comparison
Compare CXAI & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CXAI
- OVID
- Stock Information
- Founded
- CXAI N/A
- OVID 2014
- Country
- CXAI United States
- OVID United States
- Employees
- CXAI N/A
- OVID N/A
- Industry
- CXAI EDP Services
- OVID Biotechnology: Pharmaceutical Preparations
- Sector
- CXAI Technology
- OVID Health Care
- Exchange
- CXAI Nasdaq
- OVID Nasdaq
- Market Cap
- CXAI 22.4M
- OVID 20.6M
- IPO Year
- CXAI N/A
- OVID 2017
- Fundamental
- Price
- CXAI $0.89
- OVID $0.50
- Analyst Decision
- CXAI
- OVID Strong Buy
- Analyst Count
- CXAI 0
- OVID 4
- Target Price
- CXAI N/A
- OVID $3.13
- AVG Volume (30 Days)
- CXAI 487.4K
- OVID 2.5M
- Earning Date
- CXAI 08-11-2025
- OVID 08-12-2025
- Dividend Yield
- CXAI N/A
- OVID N/A
- EPS Growth
- CXAI N/A
- OVID N/A
- EPS
- CXAI N/A
- OVID N/A
- Revenue
- CXAI $6,548,000.00
- OVID $548,000.00
- Revenue This Year
- CXAI N/A
- OVID N/A
- Revenue Next Year
- CXAI $60.00
- OVID $5.32
- P/E Ratio
- CXAI N/A
- OVID N/A
- Revenue Growth
- CXAI N/A
- OVID 15.61
- 52 Week Low
- CXAI $0.76
- OVID $0.24
- 52 Week High
- CXAI $3.76
- OVID $1.47
- Technical
- Relative Strength Index (RSI)
- CXAI 37.11
- OVID 52.81
- Support Level
- CXAI $0.96
- OVID $0.60
- Resistance Level
- CXAI $1.15
- OVID $0.73
- Average True Range (ATR)
- CXAI 0.07
- OVID 0.08
- MACD
- CXAI -0.02
- OVID -0.01
- Stochastic Oscillator
- CXAI 0.95
- OVID 37.43
About CXAI CXApp Inc.
CXApp Inc is a provider of AI-powered employee experience solutions, delivering enterprise-grade software that enhances workplace engagement, productivity, and operational efficiency. The company's flagship product, the CXAI Platform, provides a comprehensive suite of tools designed to empower employees and enable organizations to create smarter workplaces. The product's key components include CXAI Apps, CXAI BTS, and CXAI-VU. The company generates the majority of its revenue from Licenses.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.